Status:
COMPLETED
Study of the Tolerability of Different SAR153191 Drug Products, That Differ With Respect to Manufacturing Processes and Formulation, at Different Concentrations and Doses in Healthy Male Subjects
Lead Sponsor:
Sanofi
Conditions:
Rheumatoid Arthritis
Eligibility:
MALE
18-65 years
Phase:
PHASE1
Brief Summary
Primary objective: To determine the tolerability of different SAR153191 drug products that differ with respect to manufacturing processes and formulation, at different concentrations and doses, after...
Detailed Description
Up to 35 Days
Eligibility Criteria
Inclusion
- Having given written informed consent prior to any procedure related to the study.
Exclusion
- Participants are excluded from the study if any of the following criteria apply:
- Any subject who, in the judgment of the Investigator, is likely to be noncompliant during the study, or unable to cooperate because of a language problem or poor mental development.
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Key Trial Info
Start Date :
July 9 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 21 2010
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT06159452
Start Date
July 9 2010
End Date
December 21 2010
Last Update
December 6 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.